Company / Free Cash Flow per Share
PTC Therapeutics, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$9.04
FY2025
5-year range
-$2.99 / $9.04
FY2021-FY2025
Trend
+699.3%
vs FY2024
Sector context
#10 of 192
Health Care
What the data says
Free Cash Flow per Share changed +699% YoY in FY2025, a notable deviation from the 9-year average annual change of +44%.
Based on SEC 10-K filings.
9.04 in FY2025. Top quartile in the Health Care sector.
Improved from $-2.56 to $9.04 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 192This company $9.04 Sector average $3.32
▼
+172.4% above sector average
Key checks
Key Insights
- PTC Therapeutics, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 699.3% year-over-year.
- Ranks #10 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.04 | +699.3% |
| FY2024 | -$1.51 | +41.0% |
| FY2023 | -$2.56 | +14.6% |
| FY2022 | -$2.99 | -85.6% |
| FY2021 | -$1.61 | -187.4% |
| FY2020 | -$0.56 | +70.6% |
| FY2019 | -$1.91 | -128.7% |
| FY2018 | -$0.83 | -116.7% |
| FY2017 | -$0.39 | +87.6% |
| FY2016 | -$3.11 | +19.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026